Stockreport

UroGen Pharma Ltd (URGN) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... [Yahoo! Finance]

UroGen Pharma Ltd. - Ordinary Shares  (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com
PDF Research and Development Expenses: $11.4 million in Q3 2024. Selling, General and Administrative Expenses: $28.9 million in Q3 2024. Net Loss: $23.7 million or 55 p [Read more]